Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
D 78.08 -2.45% -1.96
EW closed down 2.45 percent on Wednesday, February 8, 2023, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
20 DMA Support Bullish -2.45%
180 Bullish Setup Bullish Swing Setup -2.45%
NR7 Range Contraction -2.45%
Multiple of Ten Bullish Other -2.45%
Upper Bollinger Band Walk Strength -1.28%
Multiple of Ten Bearish Other -1.28%
Gapped Down Weakness -1.28%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 8 hours ago
Fell Below Previous Day's Low about 10 hours ago
Fell Below 20 DMA about 10 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
Down 1% about 11 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Edwards Lifesciences Corporation Description

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Clinical Medicine Surgery Infection Catheter Oxygen Drainage Heart Disease Artery Perfusion Incision Cardiac Surgery Repair Products Cannula Heart Cardiac Monitoring Heart Valve Cardiac Output Care Products Edwards Embolectomy Edwards Lifesciences Heart Valve Disease Valvular Heart Disease

Is EW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 131.09
52 Week Low 67.13
Average Volume 3,801,329
200-Day Moving Average 88.17
50-Day Moving Average 76.44
20-Day Moving Average 78.90
10-Day Moving Average 79.44
Average True Range 2.25
RSI 49.49
ADX 14.65
+DI 28.33
-DI 25.41
Chandelier Exit (Long, 3 ATRs) 78.10
Chandelier Exit (Short, 3 ATRs) 81.71
Upper Bollinger Bands 82.75
Lower Bollinger Band 75.05
Percent B (%b) 0.39
BandWidth 9.77
MACD Line 1.00
MACD Signal Line 1.05
MACD Histogram -0.0494
Fundamentals Value
Market Cap 48.66 Billion
Num Shares 623 Million
EPS 1.27
Price-to-Earnings (P/E) Ratio 61.72
Price-to-Sales 12.31
Price-to-Book 12.62
PEG Ratio 3.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.17
Resistance 3 (R3) 81.48 80.77 80.66
Resistance 2 (R2) 80.77 79.98 80.61 80.48
Resistance 1 (R1) 79.42 79.49 79.07 79.11 80.31
Pivot Point 78.71 78.71 78.53 78.55 78.71
Support 1 (S1) 77.36 77.92 77.01 77.05 75.85
Support 2 (S2) 76.65 77.43 76.49 75.68
Support 3 (S3) 75.30 76.65 75.51
Support 4 (S4) 74.99